| Literature DB >> 32959870 |
Brendan M O'Leary1, Andrew P Scafaro2, Ricarda Fenske1, Owen Duncan1, Elke Ströher1, Jakob Petereit1, A Harvey Millar1.
Abstract
Multiple studies have shown ribulose-1,5-bisphosphate carboxylase/oxygenase (E.C. 4.1.1.39; Rubisco) to be subject to Lys-acetylation at various residues; however, opposing reports exist about the biological significance of these post-translational modifications. One aspect of the Lys-acetylation that has not been addressed in plants generally, or with Rubisco specifically, is the stoichiometry at which these Lys-acetylation events occur. As a method to ascertain which Lys-acetylation sites on Arabidopsis Rubisco might be of regulatory importance to its catalytic function in the Calvin-Benson cycle, we purified Rubisco from leaves in both the day and night-time and performed independent mass spectrometry based methods to determine the stoichiometry of Rubisco Lys-acetylation events. The results indicate that Rubisco is acetylated at most Lys residues, but each acetylation event occurs at very low stoichiometry. Furthermore, in vitro treatments that increased the extent of Lys-acetylation on purified Rubisco had no effect on Rubisco maximal activity. Therefore, we are unable to confirm that Lys-acetylation at low stoichiometries can be a regulatory mechanism controlling Rubisco maximal activity. The results highlight the need for further use of stoichiometry measurements when determining the biological significance of reversible PTMs like acetylation.Entities:
Keywords: zzm321990 Arabidopsis thalianazzm321990 ; Rubisco; lysine acetylation; post translational modification
Mesh:
Substances:
Year: 2020 PMID: 32959870 PMCID: PMC7557146 DOI: 10.1042/BCJ20200413
Source DB: PubMed Journal: Biochem J ISSN: 0264-6021 Impact factor: 3.857
Stoichiometry of select acetyl-Lys sites on RBL determined following the creation of standard curves with heavy-labelled synthetic peptides
| Peptide | Sequence | Peptide amounts (fmol) | |||
|---|---|---|---|---|---|
| Day 1 | Day 2 | Night 1 | Night 2 | ||
| No Acetyl-K | YGRPLLGCTIKPK | 32.14 | 15.17 | 24.22 | 2.36 |
| No Acetyl-K missed cleavage | n/a | ||||
| Acetyl-K | YGRPLLGCTI(Kac)PK | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 |
| | <0.3% | <0.7% | <0.4% | <4.2% | |
| No Acetyl-K | GGLDFTK | 3.55 | 0.97 | 1.02 | 1.19 |
| No Acetyl-K missed cleavage | GGLDFTKDDENVNSQPFMR | 32.98 | 3.64 | 20.85 | 6.74 |
| Acetyl-K | GGLDFT(Kac)DDENVNSQPFMR | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 |
| | <0.3% | <2.2% | <0.5% | <1.3% | |
| No Acetyl-K | GHYLNATAGTCEEMIK | 18.06 | 6.73 | 11.20 | 6.43 |
| No Acetyl-K missed cleavage | GHYLNATAGTCEEMIKR | 1.57 | 3.13 | 7.26 | 0.35 |
| Acetyl-K | GHYLNATAGTCEEMI(Kac)R | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 |
| | <0.5% | <1.0% | <0.5% | <1.5% | |
| No Acetyl-K | LSGGDHIHAGTVVGK | 7.92 | 0.95 | 8.02 | 1.63 |
| No Acetyl-K missed cleavage | LSGGDHIHAGTVVGKLEGDR | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 | n.d. <0.1 |
| Acetyl-K | LSGGDHIHAGTVVG(Kac)LEGDR | n.d. <0.01 | n.d. <0.01 | n.d. <0.01 | n.d. <0.01 |
| | <0.1% | <1.1% | <0.1% | <0.6% | |
n.d. indicates that the signal was below the detection limit and therefore below the lowest detectable signal from the synthetic peptide standards as indicated.
Figure 1.Acetylated Lys residues detected from Arabidopsis Rubisco large subunit.
(A) Sequence of Arabidopsis RBL with a list of detected Lys-acetylation sites. Yellow highlighted Lys residues were detected to be acetylated. Grey highlighted residues were not detected to be acetylated. Boldface indicates protein sequence coverage detected by MS/MS. The list of Lys-acetylation sites contains the highest scoring peptide for each acetylation site. (B) Venn Diagram depicting the overlap of RBL acetylation sites detected among acetylomics studies.
Analysis of exogenous (heavy) and endogenous (light) acetylated peptides following in vitro Rubisco acetylation with deuterated acetic anhydride
| Lysine residue | Peptide sequence | Heavy acetylated peptide | Light acetylated peptide | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mass | Peptide MS intensity | Mass | Peptide MS intensity | ||||||||||
| Day 1 | Day 2 | Night 1 | Night 2 | Day 1 | Day 2 | Night 1 | Night 2 | ||||||
| RBL | |||||||||||||
| 18;21 | AGVK(Ac)EYK(Ac)LTYYTPEYETK | 2272.14 | 2 | 0 | 0 | 7.5 × 106 | 0 | 2269.14 | 0 | 0 | 0 | 0 | |
| 32 | LTYYTPEYETK(Ac)DTDILAAFR | 2454.20 | 2;3 | 1.3 × 106 | 0 | 1.2 × 108 | 8.5 × 107 | 2451.20 | 0 | 0 | 0 | 0 | |
| 81 | VTPQPGVPPEEAGAAVAAESSTGTWT TVWTDGLTSLDRYK(Ac)GR | 4403.17 | 4 | 0 | 0 | 3.7 × 108 | 0 | 4400.17 | 0 | 0 | 0 | 0 | |
| 146 | IPPAYTK(Ac)TFQGPPHGIQVER | 2280.21 | 2;3;4;5 | 5.9 × 108 | 1.9 × 109 | 7.3 × 109 | 4.6 × 1010 | 2277.21 | 0 | 0 | 0 | 0 | |
| 161;164 | DK(Ac)LNK(Ac)YGR | 1082.60 | 2;3 | 1.8 × 109 | 5.9 × 109 | 6.3 × 109 | 4.1 × 1010 | 1079.60 | 0 | 0 | 0 | 0 | |
| 175;177;183 | PLLGCTIK(Ac)PK(Ac)LGLSAK(Ac)NYGR | 2320.33 | 2;3;4 | 9.1 × 108 | 3.5 × 109 | 3.8 × 109 | 2.4 × 1010 | 2317.33 | 0 | 0 | 0 | 0 | |
| 201 | GGLDFTK(Ac)DDENVNSQPFMR | 2214.01 | 2;3;4;5 | 4.7 × 108 | 4.9 × 109 | 1.0 × 1010 | 7.3 × 109 | 2211.01 | 0 | 0 | 0 | 0 | |
| 252 | GHYLNATAGTCEEMIK(Ac)R | 1994.94 | 3 | 1.7 × 106 | 0 | 1.2 × 107 | 0 | 1991.94 | 0 | 0 | 0 | 0 | |
| 305 | QK(Ac)NHGMHFR | 1198.59 | 2;3 | 3.8 × 109 | 7.7 × 108 | 1.8 × 108 | 3.1 × 1010 | 1195.59 | 0 | 0 | 0 | 0 | |
| 316 | VLAK(Ac)ALR | 814.55 | 2 | 4.7 × 109 | 1.0 × 107 | 4.2 × 1010 | 8.4 × 1010 | 811.55 | 0 | 0 | 0 | 0 | |
| 334 | LSGGDHIHAGTVVGK(Ac)LEGDR | 2062.06 | 2;3;4 | 1.2 × 109 | 8.1 × 108 | 5.8 × 109 | 1.5 × 1010 | 2059.06 | 0 | 0 | 0 | 0 | |
| 356 | DDYVEK(Ac)DR | 1083.49 | 2;3 | 1.3 × 109 | 4.2 × 109 | 2.5 × 109 | 2.5 × 1010 | 1080.49 | 0 | 0 | 0 | 0 | |
| RBS | |||||||||||||
| 92 | NK(Ac)WIPCVEFELEHGFVYR[ | 2367.16 | 2;3;4 | 1.2 × 109 | 6.0 × 107 | 1.3 × 1010 | 4.8 × 1010 | 2364.16 | 3 | 0 | 0 | 3.3 × 107 | 0 |
| 140;146;147 | LPLFGCTDSAQVLK(D3_Ac)EVEECK
(D3_Ac)K(D3_Ac)EYPNAFIR[ | 3575.80 | 3 | 0 | 0 | 1.3 × 107 | 0 | 3572.80 | 0 | 0 | 0 | 0 | |
| 146;147 | EVEECK(Ac)K(Ac)EYPGAFIR[ | 2000.98 | 2;3 | 2.9 × 105 | 5.0 × 106 | 5.5 × 107 | 6.2 × 107 | 1997.98 | 0 | 0 | 0 | 0 | |
| 146;147 | EVEECK(Ac)K(Ac)EYPNAFIR[ | 1943.96 | 2;3 | 0 | 0 | 2.5 × 107 | 4.2 × 107 | 1940.96 | 0 | 0 | 0 | 0 | |
| 174 | QVQCISFIAYK(Ac)PPSFTDA[ | 1987.00 | 2;3 | 5.4 × 107 | 8.7 × 108 | 2.1 × 109 | 6.2 × 108 | 1984.00 | 0 | 0 | 0 | 0 | |
| 174 | QVQCISFIAYK(Ac)PPSFTEA[ | 2130.05 | 2;3 | 1.3 × 108 | 4.6 × 108 | 5.5 × 108 | 9.6 × 108 | 2127.05 | 0 | 0 | 0 | 0 | |
| 174 | QVQCISFIAYK(Ac)PPSFTG[ | 2116.04 | 2;3 | 7.6 × 107 | 2.0 × 108 | 2.8 × 106 | 3.2 × 108 | 2113.04 | 0 | 0 | 0 | 0 | |
At1G67090;
At5G38410;
At5G38420;
At5G38430.
Figure 2.Peptide substrate assays for Lys-deacetylase activity in Arabidopsis crude leaf extracts.
The ratio of acetylated to non-acetylated versions of four synthetic peptides are quantified by MRM following incubations of the synthetic peptides in crude leaf extract for 2 h with or without deacetylation inhibitors. Separate peptide incubations were performed in the presence of hSirt3. Asterisks indicate significant differences compared with the corresponding 0 h controls (ANOVA and Holm-Sidak post-hoc test, P < 0.05, n ≥ 3).
Figure 3.Rubisco maximal activity measurements following Lys-acetylation treatments. (A) Purified leaf Rubisco samples were subject to in vitro deacetylation (deAc) and acetylation treatments with acetyl-CoA (+Ac) or acetic anhydride followed by SDS–PAGE and western blotting with anti-acetyl-lysine antibodies. The lower panel shows the total protein of the stain-free gel prior to immunoblotting performed using UV fluorescence. 300 ng of protein was loaded per lane except for the lane containing acetic anhydride treated Rubisco which contains 3 ng. (B) The relative intensity of each band in (A) was measured as the ratio of western blot signal intensity to total protein signal intensity of the RBL band. The corresponding total RBL protein band in the +acetic anhydride sample was below the detection limit. (C) Acetyl-CoA and control-treated samples were assayed for Rubisco maximal activity. Analysis by two-way ANOVA indicated non-significant effect of the acetyl-CoA treatment but a significant day-night effect as indicated by the asterisk (P < 0.05, Holm-Sidak post-hoc test). Error bars represent standard error of the mean of three technical replicates.